North America Phenolic Resin Market To Gain From Rising Usage In Applications As Wood Adhesives, Laminates And Coatings Till 2024: Grand View Research, Inc.

The global automotive tire market size is expected to reach USD 374.22 billion by 2024 according to a new report by Grand View Research, Inc. Increasing automotive sales especially in countries such as China, India, Japan, and South Korea is anticipated to favorably impact the global automotive tire market over the forecast period. This growth can be attributed to rising disposable income and improvement in the overall lifestyle of consumers.
Technological proliferation and the development of the innovative and environment-friendly green tires have opened up broad growth avenues for the industry participants. Moreover, increasing radial tire up gradation activities owing to its benefits such lesser vibrations, reduced fuel consumption and extended tire life due to less heat generated has favorably impacted the industry growth.
However, stringent emission norms by governments and regulatory authorities worldwide are expected to challenge demand. For example, on September 1, 2010, the California Air Resources Board’s (ARB’s) Tire Pressure Regulation was formulated to reduce greenhouse gas emissions from vehicles operating with underneath inflated tires by inflating them to the suggested pressure rating.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/automotive-tire-market

Further key findings from the report suggest:

·         Two wheelers segment is anticipated to grow at CAGR of over 7.5% from 2016-2024. Increasing demand for two-wheelers across the developing countries such as India and China will contribute to the segment growth.

·         Increasing manufacturing and infrastructure building activities have spurred the sales of light commercial vehicles (LCV). Growing number of LCVs in Europe has led EU regulatory bodies and OEMs to enhance and improve the safety aspects of LCVs. The passenger car segment dominated the industry with over 40% revenue share in 2015 owing to the increasing advancements and innovations such as Plug-in cars.

·         The tire industry has witnessed a remarkable shift from the traditional to the technically advanced radial products. Radialisation of the truck tire market is anticipated to fuel the demand over the forecast period. In 2012, manufacturers in China produced over 50% of the global radial truck tires industry.

·         Stringent government guidelines worldwide are expected to regulate the global automotive tire market over the coming years. Asia Pacific dominated the industry contributing to over 40% of the global revenue in 2015. The presence of several prominent automobile manufacturers and ancillaries in the region is expected to generate high demand over the forecast period.

·         Key industry participants include Bridgestone, Continental, Goodyear, Michelin, Pirelli and Sumitomo. Manufacturers are gradually adopting innovative production techniques to gain a competitive advantage over others. Vendors are now adopting modern supply chain and distribution strategies such as e-commerce and retail chains to reach efficiently the end-user apart from the conventional supply to automobile assemblers and aftermarket industry.

Read detailed report or request for sample of this research report: - http://www.grandviewresearch.com/industry-analysis/automotive-tire-market/request

Grand View Research has segmented the global automotive tire market on the basis of application, type and region:
Automotive Tire Application Outlook (Revenue, USD Billion, 2014 - 2024)

·         Passenger cars

·         LCV

·         HCV

·         Two wheelers

Automotive Tire Type Outlook (Revenue, USD Billion, 2014 - 2024)

·         Radial

·         Bias

Automotive Tire Regional Outlook (USD Billion, 2014 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         RoW

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/technology

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States           

Phone:  1-415-349-0058

Toll Free:  1-888-202-9519

Email:  sales@grandviewresearch.com 

Website:  Grand View Research                          

Blog Site: mediafound.org, grandviewresearch.com/blogs/technology

Hyaluronic Acid Market Is Projected To Develop Swiftly, To Reach $13.4 Billion By 2024: Grand View Research, Inc.

The global hyaluronic acid market is expected to reach USD 13.4 billion by 2024, according to a new report by Grand View Research. Factors such as increasing concern in population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact-rendering drivers of this market.
The market is evolving rapidly due to the increasing adoption of aesthetic procedures in both developed and developing regions. The growing geriatric population coupled with growing awareness about antiaging products and aspiration to look healthy and young is fueling the market for all cosmetics. The efficacy and evident results of hyaluronic acid-based dermal fillers are attracting this population base.
The increase in obesity resulting in osteoarthritis and joint pain has boosted the demand for hyaluronic acid injections as treatment. In 2012, approximately 53 million people were diagnosed with osteoarthritis and it is projected that by 2040, the number will grow to 78 million. This can be anticipated as exponential growth in demand for hyaluronic acid injections.
Moreover, mounting number of obese people indicates the growing number of people suffering from orthopedic disorders. There is no permanent cure for these disorders and treatment includes use of pain killers. However, hyaluronic acid-based viscosupplements are seen as a possible cure or at least a better option to joint pain.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/hyaluronic-acid-market

Further Key Findings from the Study Suggest:

·         In 2015, dermal fillers dominated the application segment due to increasing awareness about the available aesthetic procedures and approval of effective products by the FDA. For instance, in 2013, the U.S. FDA approved hyaluronan-based facial fillers to be used in corrective measures, filling fine lines, and antiaging procedures. These dermal fillers constitute a large share in these procedures and witnessed 8% growth in the year 2014. Cosmetic surgeries market is booming with approximately 14 million minimally invasive procedures being performed every year.

·         Pharmaceutical-grade hyaluronan holds the largest share in terms of raw material used for products. It is available in a wide range of molecular weights and manufacturers also provide customized hyaluronic acid, especially for research purposes.

·         In 2015, non-animal based hyaluronan held the largest share of the source segment. It is extracted from recombinant bacteria and has uniform molecular weight; therefore, it is preferred for research purposes. Furthermore, non-animal based hyaluronic acid is preferred as the raw material for the production of food supplements. It eliminates the risk of cross-contamination and the varied molecular weight does not affect the quality of the products.

·         In 2015, North America dominated the market with a revenue share of over 40%. In 2009, the first viscosupplement Synvisc-One, by Genzyme Corporation, was approved in the U.S. and gained quick popularity owing to its efficacy and ease of use.

·         Increase in understanding of aging processes coupled with the interest in dermal fillers boosted the demand for antiaging procedures in this region. Presence of market leaders such as Genzyme Corporation and Anika Therapeutics in this region also contributes to fueling customer awareness and acceptance as a result of aggressive marketing strategies of these companies.

·         Asia Pacific is anticipated to emerge as the fastest growing region during the forecast period. The growing geriatric population in Japan and China provides a large customer base for antiaging products and services. Moreover, Asian population is influenced by western beauty standards and aims for volumized appearance. This has resulted in 14% growth of dermal filler market as compared to the 7% in North America.

·         Some key participants of the market are Anika Therapeutics, Inc.; Seikagaku Corporation; Galderma S.A.; Sanofi (Genzyme); Salix Pharmaceuticals; Allergan, Inc.; F. Hoffmann-La Roche Ltd., Zimmer Holdings, Inc.; Ferring Pharmaceuticals, Inc.; and Smith & Nephew Plc.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the hyaluronic acid market by product, application, raw material (source, grade), and region:
Hyaluronic Acid Market Product Outlook (Market revenue in USD Million, 2013 - 2024)

·         Single Injection

·         Three-injection

·         Five-injection

Hyaluronic Acid Market Application Outlook (Market Revenue in USD Million, 2013 - 2024)

·         Dermal fillers

·         Osteoarthritis

·         Ophthalmic

·         Vesicoureteral reflux

Hyaluronic Acid Market Raw Material (by Grade) Outlook (Market Revenue in USD Million, 2013 - 2024)

·         Pharmaceutical grade

·         Cosmetic grade

·         Food grade

Hyaluronic Acid Market Raw Material (by Source) Outlook (Market Revenue in USD Million, 2013 - 2024)

·         Animal based

·         Non-animal based

Hyaluronic Acid Market Regional Outlook (Market Revenue in USD Million, 2013 - 2024)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

o    France

o    Italy

o    Russia

·         Asia Pacific

o    Japan

o    China

o    South Korea

·         Latin America

o    Brazil

o    Mexico

·         Middle East and Africa

o    South Africa

For press release of this report - http://www.grandviewresearch.com/press-release/global-hyaluronic-acid-market

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States           

Phone:  1-415-349-0058

Toll Free:  1-888-202-9519

Email:  sales@grandviewresearch.com 

Website:  Grand View Research                          

Blog Site: mediafound.org, grandviewresearch.com/blogs/healthcare

Biosimulation Market Is Expected To Reach USD 3.77 Billion By 2024: Grand View Research, Inc.

The biosimulation market is expected to reach USD 3.77 billion by 2024, according to a new study by Grand View Research, Inc. The unprecedented global shift in the adoption of unhealthy lifestyles is resulting in the high prevalence of chronic diseases, such as cancer and diabetes, is expected to drive the biosimulation market during the forecast period. In addition, the rising geriatric population base highly susceptible to acquire the aforementioned chronic diseases result in enhanced demand for highly efficacious pharmacological drugs. This high requirement of efficacious drugs can be effectively met at a faster rate through the incorporation of the in silico approach, thus creating a high potential for biosimulation market growth opportunities in the future. Furthermore, increasing drug resistance, high drug failure rate, and availability of limited drugs to treat several diseasessuch as AIDS, pneumonia, tuberculosis, and others indicate the indisputable requirement for the incorporation of biosimulation in the drug discovery and development process. The widespread application of the in silico approach to developing efficacious drugs would generate drugs of greater potency in the market within a shorter span.
The increasing demand can be attributed primarily to the significant cost reduction in the clinical trials and drug development & discovery process. This is due to the fact that the in silico software can predict adverse reactions, toxicity, and efficacy of the drugsin the early stages of the drug development, thereby reducing the probability of drug failure at the later stages and consequentially, control the overall expenditure. These above-mentioned factors serve as key reasons responsiblefor the heightened market demand.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/biosimulation-industry

Further key findings from the study suggest:

·         The services segment is expected to exhibit growth at a significant CAGR of over 16.0% during the forecast period. This is a consequence of rising inclination of the big pharmaceutical companies to outsource their biosimulation process so as to reduce the overall cost incurred in research and development and divert its focus toward their core capabilities.

·         The drug discovery segment is anticipated to witness an exponential CAGR of over 15.0% in the application segment. Associated benefits of biosimulation in drug discovery are anticipated to fuel the demand over the forecast period. These benefits include the elimination of potential drug failures, predict unfavorable drug interactions, and anticipate potential risks.

·         In addition to these, certain other advantages include increased drug efficacy through the evaluation of optimal synergistic combinations, enable study of the mechanistic actions of drugs, and identification ofthe most suitable dosage forms, which render the drug discovery segment a profitable zone.

·         In 2015, the pharmaceutical and biotechnology companies held a substantial share of this vertical of over 58.0% in 2015. This can be attributed to the consistent efforts of these companies to develop better medication options at a faster and cheaper rate through in silico biology techniques.

·         Likewise, the academic research applications are presumed to witness constant growth as a consequence of the presence of various academic research groups that are involved in the study of complex biological systems using computer models, such as by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

·         In 2015, North America dominated the overall biosimulation marketat over 50.0%. The presence of regulatory authorities, consistently inclined towards ensuring patient safety, is a crucial factor presumed to be responsible for the dominant market share ofthis region. Moreover, the presence of highly skilled professionals also serves as a significant growth driver.

·         The numerous collaborations amongst the leading playersthat are being undertaken to promote the incorporation of biosimulation systems are expected to be responsible for bolstering the growth inthis region. For instance, Entelos, Inc. collaborated with Bayer AG to develop novel gene-based drug targets and also with Johnson & Johnson, Inc. to optimize clinical trial designs through in silico models.

·         Some of the leading players in this industry include Certara USA, Inc., Simulation Plus, Inc., Dassault Systems SA, Rhenovia Pharma Ltd., and Evidera, Inc. These players are actively involved in initiating collaborative strategies and frequent product launches to capture a larger share of the vertical.For instance, In April 2016, Simulation Plus, Inc. launched the DDDPlus Version 5.0, invitro dissolution experiment software. This upgraded version includes improvements in functionalities of the software that enable scientists and researchers to study the behavior of different pharmaceutical dosage forms.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the biosimulation marketon the basis of product, application,enduse and region:

Global Biosimulation Product Outlook (Revenue, USD Million, 2013 - 2024)

• Software
• Services
• In-house Services
• Contract Services

Global Biosimulation Application Outlook (Revenue, USD Million, 2013 - 2024)

• Drug Development
• Drug Discovery
• Others

Global Biosimulation End-use Outlook (Revenue, USD Million, 2013 - 2024)

• Pharmaceutical & Biotechnology Companies
• CROs
• Regulatory Authorities
• Academic Research Institutions

Biosimulation Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• India
• Latin America
• Mexico
• Brazil
• MEA
• South Africa

For press release of this report - http://www.grandviewresearch.com/press-release/global-biosimulation-market

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States           

Phone:  1-415-349-0058

Toll Free:  1-888-202-9519

Email:  sales@grandviewresearch.com 

Website:  Grand View Research                          

Blog Site: mediafound.org, grandviewresearch.com/blogs/healthcare